Johnson & Johnson vs. Mirum Pharmaceuticals, Inc. Common Stock
Johnson & Johnson (JNJ) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| JNJ | MIRM | |
|---|---|---|
| Market Cap | $651.20 billion | $6.53 billion |
| Revenue (TTM) | $97.93 billion | $618.07 million |
| Net Income (TTM) | $21.04 billion | $-860,207,000 |
JNJ leads on 3 of 3 size & scale factors.
Valuation
| JNJ | MIRM | |
|---|---|---|
| P/E Ratio | 31.51 | — |
| Price / Book | 7.66 | -626.83 |
| Price / Sales | 6.65 | 10.57 |
JNJ and MIRM split the valuation factors evenly.
Profitability
| JNJ | MIRM | |
|---|---|---|
| Net Margin | 21.48% | -139.18% |
| Return on Equity | 24.76% | 8253.76% |
JNJ and MIRM split the profitability factors evenly.
Dividend
| JNJ | MIRM | |
|---|---|---|
| Dividend Yield | 1.97% | — |
| Payout Ratio | 62.18 | — |
JNJ and MIRM split the dividend factors evenly.
Risk & Sentiment
| JNJ | MIRM | |
|---|---|---|
| Short Interest | 0.67% | 0.09% |
MIRM leads on 1 of 1 risk & sentiment factors.
Dig deeper: JNJ overview, JNJ financials, MIRM overview, MIRM financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.